Basic Materials
Live Price
Offline$0.162
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 → Apr 6, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 198 bars · Jun 23, 2025 → Apr 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
China Sanjiang Fine Chemicals Company Limited (CNSJF) is a Basic Materials stock with a market cap of $187.57M. The stock last traded around $0.16 and up 0.0% across the available one-year price window (Jun 23, 2025 → Apr 6, 2026). Baseline metrics include revenue growth of +49.2%, EPS growth of +486.7%, a dividend yield of 0.0%. What stands out right now is revenue +49.2%, EPS +486.7%, free cash flow +69.1% with operating margin 2.9% and ROIC 2.4%. Valuation is more restrained than many high-expectation growth names at P/E 13.6 and price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CNSJF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CNSJF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CNSJF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CNSJF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$8.3B
-12.4% YoY
FY Net Income
$1.1B
+195.0% YoY
Free Cash Flow
-$209.1M
+74.9% YoY
Revenue Growth
+49.2%
EPS Growth
+486.7%
Gross Margin
4.4%
Net Margin
2.2%
Income statement
CNY
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 19.6B | 13.1B | 8.8B | 9.5B | 8.3B |
| Gross Profit | 1.1B | 194M | -70M | 635M | 1.6B |
| Operating Income | 1.0B | 120M | -266M | 352M | 1.2B |
| EBITDA | 2.1B | 813M | 349M | 389M | 1.6B |
| Net Income | 533M | 91M | -308M | 381M | 1.1B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 564M | 364M | 217M | 594M | 776M |
| Total Assets | 22.1B | 21.0B | 18.3B | 14.3B | 11.0B |
| Total Liabilities | 17.2B | 16.6B | 13.9B | 9.5B | 6.2B |
| Shareholder Equity | 4.9B | 4.4B | 4.3B | 4.7B | 4.7B |
| Total Debt | 11.0B | 10.3B | 10.5B | 6.3B | 4.2B |
| Net Debt | 10.4B | 9.9B | 10.3B | 5.7B | 3.4B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.7B
+6.9% YoY
Capital Expenditures
1.9B
+20.8% YoY
Free Cash Flow
209M
+74.9% YoY
Key ratios
Gross Margin
4.4%
Operating Margin
2.9%
Net Margin
2.2%
ROE
7.7%
Debt / Equity
2.22x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.